SpeedWeed

JULY 6, 2021

The US Food and Drug Administration is also currently sponsoring clinical trials that could lead to the federal legalization of psilocybin- and MDMA -assisted therapy within the next two years.

Policy 52

Policy Law Research and Development Therapy 52

The Cannigma

AUGUST 31, 2021

Medical societies are slowly providing more CME (continuing medical education) to doctors on cannabis, however, that educational content tends to be slanted toward risk mitigation. Fortunately, there is a slowly growing community of cannabis physicians who are learning through trial and error and from one another.

Education 101

Education Clinical Trials Medicine Policy 101

Cannabis Law Report

SEPTEMBER 14, 2021

13, 2021 /PRNewswire-PRWeb/ — A host of scientific research and clinical trials around the world are affirming the remarkable effectiveness of psilocybin, the principal psychoactive component of “magic mushrooms,” in the treatment of a variety of medical conditions, including depression, anxiety, addiction, and PTSD.

Clinical Trials 52

Clinical Trials Events Medicine Therapy 52

Cannabis Law Report

AUGUST 7, 2022

In recent years, as more clinical trial results show that psychedelics can be used in conjunction with therapy to treat illnesses like depression and post-traumatic stress disorder, legislators pushed to make certain substances available in certain settings. But these substances remain illegal under federal law.

Law 74

Law Research and Development Therapy Treatment 74

Cannabis Law Report

SEPTEMBER 10, 2019

Forbes reported on Hopkins researchers’ recommendation that, if psilocybin should clear Phase III clinical trials, the FDA should reclassify it from a Schedule I to a Schedule IV drug. Dr. Johnson speaks with Denver NBC News, offering his thoughts on the Denver initiative to decriminalize psilocybin.

Research and Development 45

Research and Development Microdosing Clinical Trials Decriminalization 45

Cannabis Law Report

JANUARY 14, 2020

The MORE Act would decriminalize marijuana and THC at the federal level by removing it from Schedule I of the Controlled Substances Act, which currently classifies it as an addictive drug that has no accepted medical use, akin to heroin. 2843, Marijuana Freedom and Opportunity Act. 1151, Veterans Medical Marijuana Safe Harbor Act.

Clinical Trials 69

Clinical Trials Programs Access DEA 69

The Cannigma

AUGUST 26, 2021

Medical: Legal Recreational: Illegal (though at least one territory has adopted decriminalization). These products can only be accessed through the Special Access Scheme by an authorized healthcare practitioner, or as part of a clinical trial, according to the Office of Drug Control. Costs of medical marijuana.

Legalization 52

Legalization Access Medicine Clinical Trials 52

SpeedWeed

SEPTEMBER 16, 2021

Many cities have decriminalized psychedelics, and the state of Oregon has decriminalized all drugs and is currently setting up a framework for administering psilocybin in a clinical setting. A clinical trial on MDMA is set to finish in 2022, which could lead to FDA approval. CH: That’s absolutely true.

Education 86

Education Decriminalization Research and Development Clinical Trials 86

Cannabis Law Report

JULY 21, 2022

By decriminalizing cannabis at the federal level, the CAOA also ensures that state-legal cannabis businesses or those in adjacent industries will no longer be denied access to bank accounts or financial services simply because of their ties to cannabis.

Safety 52

Safety Legislation Clinical Trials Banking 52

The Cannigma

MARCH 12, 2021

MSO: So much of that has to do with the lack of education among medical professionals, but also the lack of scientific information, saying which cannabis products are good for what symptoms or what conditions and hopefully, we get there one day. So, I guess kind of like a doctor who is providing educational medical services to patients.

Legalization 128

Legalization Patients Education Dispensary 128

The Cannigma

MAY 7, 2021

Now, that’s going to matter significantly when as we advance clinical trials, as we advance product formulation as not just product formulation within pharma but all product formulation and that comes down to the initial process in relation to the supply chain of pretty hardcore standardization.

Supply Chain 120

Supply Chain Patients Access Hemp 120

Cannabis Law Report

JUNE 4, 2021

Through his social media outlets, podcast, blog, and interviews, Tim has educated hundreds of millions of people about psychedelics. Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

JUNE 10, 2021

Male, younger, lower-income, and lower-education respondents self-reported driving after marijuana use more than their demographic counterparts, more often reported such behavior to be personally acceptable, and exhibited lower support per-se laws. Between 2013 and 2017, approximately 3000 TSCI surveys were completed annually.

Policy 59

Policy Safety Marijuana Data 59

Cannabis Law Report

DECEMBER 30, 2019

State lawmakers passed Assembly Bill 420 , which authorizes the University of California’s Center for Medicinal Cannabis Research to cultivate cannabis for clinical trials. State lawmakers passed HB 1383 , which decriminalizes activities involving the possession of up to three grams of marijuana. California.

Legislation 59

Legislation Patients Access Banking 59